Seeing Is Believing
Analyst Andrew Paine, currently employed at CLSA,
Most recent stock forecast was given on RMD, ResMed at 17-Jul-2025.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$290
$35.6 (13.99%)
$286
2 months 22 days ago
(24-Apr-2025)
14/18 (77.78%)
$53.9 (22.83%)
310
Hold
$248
$-6.4 (-2.52%)
$260
2 months 22 days ago
(24-Apr-2025)
2/3 (66.67%)
$11.9 (5.04%)
19
Buy
$285
$30.6 (12.03%)
$250
2 months 22 days ago
(24-Apr-2025)
5/6 (83.33%)
$48.9 (20.71%)
30
Hold
5 months 15 days ago
(31-Jan-2025)
11/11 (100%)
$-7.67 (-3.15%)
212
Buy
$250
$-4.4 (-1.73%)
$215
9 months 16 days ago
(30-Sep-2024)
11/11 (100%)
$6.95 (2.86%)
115